Hepatitis C Genotype Guides Health Plans
Genotype Testing Is Crucial to Course of Therapy for Hepatitis C Patients December 30, 2008 Reprinted from SPECIALTY PHARMACY NEWS,... View Article
Continue reading »Research & Treatment News
Share
Follow Us
Foretelling Hepatitis C Drug Success
By utilizing a mathematical formula on the specific genetics of an individual's Hepatitis C infection, doctors may be able to predict whether or not treatment will be successful.
Continue reading »Treatment Approved for Kids With Hepatitis C
Instead of prescribing the drugs for "off-label use," pediatricians can now feel more confident when treating children with Hepatitis C. Schering-Plough's Rebetol and PEG-Intron have been officially approved by the FDA for treating Hepatitis C in kids aged 3 to 17.
Continue reading »Improving Chronic Hepatitis Outlook: Umbilical Cord Blood
A potential alternative to liver transplant surgery, stem cells from umbilical cord blood may be the solution that those living with chronic hepatitis have been looking for.
Continue reading »Who Is Susceptible to Alcoholic Hepatitis?
The relationship between drinking alcohol and developing alcoholic hepatitis is not necessarily linear. Aside from consuming alcohol, learn which other factors – such as obesity and malnutrition – can play a role in developing this potentially life-threatening liver disease.
Continue reading »Europe Approves Hepatitis C Re-Treatment Protocol
In response to a large, Roche-sponsored study, the European Commission approved Pegasys and Copegus for re-treating Hepatitis C non-responders.
Continue reading »Interferon Inappropriate for Long-Term Hepatitis C Treatment
The results are in from a 3-1/2 year study of long-term interferon treatment against the Hepatitis C virus. By examining clinical outcomes, researchers evaluated whether or not long-term use of interferon would be helpful or even appropriate for HCV patients.
Continue reading »Hep C Study Reveals Taribavirin a Good Alternative to Ribavirin
At the end of a 48-week, Phase IIb study, taribavirin shows similar effectiveness as ribavirin in reducing Hepatitis C viral load. However, participants taking taribavirin had a significantly lower rate of anemia.
Continue reading »Schering-Plough Developing Potent Protease Inhibitor for Hepatitis C
An ongoing Phase IIa study on Schering-Plough’s next generation Hepatitis C protease inhibitor is encouraging. According to the company, SCH... View Article
Continue reading »New Drug Finds Viral Hiding Spots
A new, experimental drug helps the immune system locate a virus by flagging cells that have turned inside out. Hepatitis C is among the viruses that could benefit from bavituximab's unique strategy of exposing a virus in hiding.
Continue reading »
